PMID: 19943213Nov 28, 2009Paper

Coronary Artery Disease - Eighth International Congress. From prevention to intervention

IDrugs : the Investigational Drugs Journal
Norman C W Wong

Abstract

The International Congress on Coronary Artery Disease, held in Prague, included topics covering new developments in the field of therapeutics for cardiovascular diseases. This conference report highlights selected presentations on clinical and basic research, including the future of interventional cardiology, treatments to accompany percutaneous coronary intervention, vascular closure devices, the use of heparin and clopidogrel, applying differential matrix metalloprotease profiling and microRNAs to identify patients for treatment, targeting cathepsins in atherosclerosis, and targeting cholesterol in cardiovascular disease. Investigational drugs discussed include FX-06 (Ikaria Holdings Inc) and RVX-208 (Resverlogix Corp).

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

IDrugs : the Investigational Drugs Journal
Claire Veryard
IDrugs : the Investigational Drugs Journal
Andrea Leone-Bay
IDrugs : the Investigational Drugs Journal
Gaetano Romano
© 2022 Meta ULC. All rights reserved